Objective: To compare the risk of repeat prostatectomy for benign prostatic hyperplasia (BPH) in a population-based cohort of 19 598 men in Western Australia treated by transurethral resection of the prostate (TURP) or open prostatectomy over a 16-year period.

Patients And Methods: The Western Australian Health Services Research Linked Database was used to extract all hospital morbidity data, death records and prostate cancer registrations for men who had prostate surgery for BPH in 1980-95. The cumulative incidence of first repeat prostatectomy calculated using the actuarial life-table and incidence-rate ratios of the first repeat prostatectomy, comparing TURP and open prostatectomy, were obtained using Cox regression.

Results: The cases comprised 18 464 TURPs and 1134 open prostatectomies, from which there were 1095 subsequent repeat prostatectomies. After adjustment for calendar time, age and admission type, the incidence rate of the first repeat prostatectomy was up to 2.30 times higher (95% confidence interval, 1.62-3.27) after initial TURP than for initial open prostatectomy. The absolute risks at 8 years for TURP was 6.6%, and was 3.3% for open prostatectomy.

Conclusion: The absolute risk of a repeat prostatectomy for TURP and open prostatectomy were consistent with the best reported international experience. There was evidence that the risk in 1990-95 had declined compared with earlier periods, despite a shift towards more closed procedures. The differential risks of repeat prostatectomy should be explained to patients and considered in the development of clinical guidelines, notwithstanding the advantages of TURP over open prostatectomy in terms of surgical morbidity and cost.

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1464-410x.1999.00359.xDOI Listing

Publication Analysis

Top Keywords

repeat prostatectomy
28
open prostatectomy
20
turp open
16
prostatectomy
12
risk repeat
8
repeat
7
open
7
turp
6
trends repeat
4
prostatectomy surgery
4

Similar Publications

In this report, we present a progressively enlarging, degenerative, intraspongious/intravertebral herniated nucleus pulposus, also referred to as a "Schmorl's node," in a 65-year-old patient with a history of prostate cancer. The patient initially presented to our orthopedic oncology clinic for the evaluation of lytic-appearing lesions involving the L4 and L5 vertebral bodies. He had been diagnosed with prostate cancer approximately four years prior and had been previously treated with prostatectomy.

View Article and Find Full Text PDF
Article Synopsis
  • Prostate cancer (PCa) is a significant global health issue, and the Gleason Score (GS) is crucial for predicting patient outcomes, highlighting the importance of accurate preoperative biopsy assessments.
  • A retrospective study of 110 male PCa patients revealed correlations between biopsy parameters and postoperative pathological features, indicating that longer tumor lengths and higher grade groups on biopsy are linked to worse outcomes like positive surgical margins and extraprostatic extension.
  • The research uncovered that undergrading occurred more frequently in biopsy samples (30.90%) than overgrading (6.36%), suggesting that certain biopsy characteristics, such as tumor length and percentage, enhance grading accuracy.
View Article and Find Full Text PDF
Article Synopsis
  • The study looked at men's experiences after getting an artificial urinary sphincter (AUS) surgery again after having it fixed multiple times.
  • Most men felt good about their initial surgery, but some didn't know the device needed future fixes and wanted better follow-up care.
  • Overall, the AUS helped reduce how many pads they used for incontinence, showing it worked well for most of them.
View Article and Find Full Text PDF

Background: Patients with prostate adenocarcinoma undergoing regular endocrine therapy may maintain normal PSA levels during follow-up, yet still progress to the highly malignant and rare prostatic sarcomatoid carcinoma, which is seldom reported. This article presents two case studies of prostatic sarcomatoid carcinoma. To date, only a few publications have described prostatic sarcomatoid carcinoma, and the clinical, morphological, and molecular dimensions of prostate adenocarcinoma warrant further investigation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!